Medivir

1.90 SEK

-1.24%

Less than 1K followers

MVIR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Medivir

EV/S

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)8.345.589.188.112.852.840.41
Shares36.136.164.468.0104.5112.2448.7
Market cap301.2201.6591.4551.8297.8318.6183.5
Enterprise value166.6131.6370.2426.0128.2256.164.3
EV/S19.19.514.596.816.973.27.6
EV/EBITDAneg.neg.neg.neg.neg.neg.neg.
EV/EBITneg.neg.neg.neg.neg.neg.neg.
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B1.631.422.102.861.372.760.69
P/S34.614.523.2125.439.291.021.6
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio62.8 %74.1 %83.7 %82.3 %75.7 %66.9 %86.3 %
Gearing ratio-------